Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · IEX Real-Time Price · USD
3.660
-0.040 (-1.08%)
At close: Jul 19, 2024, 4:30 PM
3.910
+0.250 (6.83%)
Pre-market: Jul 22, 2024, 8:00 AM EDT
Puma Biotechnology Employees
Puma Biotechnology had 185 employees as of December 31, 2023. The number of employees decreased by 7 or -3.65% compared to the previous year.
Employees
185
Change (1Y)
-7
Growth (1Y)
-3.65%
Revenue / Employee
$1,225,016
Profits / Employee
$83,108
Market Cap
176.55M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Accuray | 1,024 |
OrganiGram Holdings | 984 |
Metagenomi | 236 |
Biomea Fusion | 103 |
MediWound | 100 |
Acumen Pharmaceuticals | 52 |
Candel Therapeutics | 42 |
Fennec Pharmaceuticals | 29 |
PBYI News
- 3 days ago - Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial Results - Business Wire
- 19 days ago - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 weeks ago - Puma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung Cancer - Business Wire
- 7 weeks ago - Puma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041) - Business Wire
- 7 weeks ago - Puma Biotechnology to Join Russell 3000 Index - Business Wire
- 2 months ago - Puma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual Meeting - Business Wire
- 2 months ago - Puma Biotechnology Reports First Quarter Financial Results - Business Wire
- 3 months ago - Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results - Business Wire